These are the two South Korean implant brands a UK patient is most likely to be offered for treatment abroad — Osstem the higher-volume of the two, MegaGen best known for AnyRidge. Both are value-segment brands, and a treatment plan naming only the brand has not identified which of its several distinct implant systems was used.
Side by side
Rows appear only where at least one side has data. Where a value is not verified we say
so rather than leaving it blank.
Sold through subsidiaries across more than 90 countriesManufacturer-reported[3]
The biggest differences
Osstem, founded in 1997 and based in Seoul with manufacturing centred on Busan, presents its TS family as its flagship. MegaGen, based in Daegu, is behind AnyRidge, AnyOne, BlueDiamond and ARi — separate implant designs rather than trim levels of one product. Both are Korean, both are widely placed abroad, and both require the specific system named before a component can be ordered.
Prosthetic ecosystem
Neither brand's components interchange with the other's, and within each brand the system matters: Osstem's TS line shares one connection across its variants, while MegaGen's AnyRidge (5 degree Morse taper) and AnyOne (11 degree internal hex) use different connections from each other. So 'a MegaGen implant' is even less specific than 'an Osstem implant', because MegaGen's own systems are not mutually compatible.
Geographic availability and serviceability
Osstem states it sells through subsidiaries across more than 90 countries and is among the highest-volume implant brands in the world, which is a reasonable proxy for parts being obtainable. We hold less on MegaGen's distribution, and our MegaGen brand record is database-only because the manufacturer's own pages do not give a founding date or a clear ownership structure — both things a reader would reasonably expect and which we would rather leave blank than borrow from a directory.
Cost considerations
Both sit in the value segment of the implant market, so the price distinction between them is smaller than between either and a premium brand. Price positioning is a market fact and not a quality signal; the meaningful differences between the two are in which specific systems each offers and how well supported they are where the patient lives.
What may influence clinical selection
For a UK patient, the practical questions with either Korean brand are the same: which exact system and connection was used, whether a dentist at home can obtain the matching parts, and whether the treating clinician is experienced with it. The brand name settles none of these, and the choice between two value brands is rarely the decisive factor in the outcome.
So which is better?
Neither is universally better, and any page telling you otherwise is selling something.
These are different designs with different trade-offs, and the right choice depends on the
bone available, the position in the mouth, the planned restoration, and what the treating
clinician is equipped and experienced to place and to service years from now.
That last point is easy to overlook and matters more than most specification
differences: components need to remain obtainable for as long as the implant is in place.
Regulatory record
US FDA 510(k) clearances held by each side, retrieved from the FDA's own database.
MegaGen
8
FDA 510(k) clearances
2011 – 2026
Filed by Megagen Implant Co., Ltd.
Osstem
5
FDA 510(k) clearances
2016 – 2023
Filed by Osstem Implant Co., Ltd.
A clearance count is not a quality ranking, and the
larger number is not the better implant. A brand with more clearances usually
has a longer history or a broader component range. FDA "clearance" also is not FDA
"approval" — it means the device was accepted as substantially equivalent to one already
on the market, generally without a clinical trial. A blank here means we could not match
a filing with confidence, not that the brand lacks authorisation.
What these actually mean →
Sources
Numbers match the citations beside each claim above.
